KMDA Kamada Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: KMDA

Price (delayed)

$7.26

Market cap

$418.8M

P/E Ratio

20.74

Dividend/share

$0.25

EPS

$0.35

Enterprise value

$397.52M

?
Relative Growth: Rel. Growth: 44
Relative Strength: Rel. Strength: 27
Relative Valuation: Rel. Valuation: 71
Relative Profitability: Rel. Profitability: 66

Kamada Ltd. (the “Company”) is a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived therapeutics, with a diverse portfolio of marketed products, a robust development pipeline and industry-leading manufacturing ...

Highlights
KMDA's net income is up by 27% year-on-year
Kamada's EPS has increased by 21% YoY
KMDA's equity is down by 3.6% since the previous quarter but it is up by 2.9% year-on-year
KMDA's quick ratio is down by 17% since the previous quarter
KMDA's gross margin is down by 7% year-on-year and by 2.6% since the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.kamada.com
Peers: VSTM RGEN ATRA

Key stats

What are the main financial stats of KMDA

KMDA stock price

How has the Kamada stock price performed over time
Intraday
5.52%
1 week
1.68%
1 month
1.26%
1 year
-1.63%
YTD
2.83%
QTD
-1.09%

Financial performance

How have Kamada's revenue and profit performed over time
Revenue
$181.68M
Gross profit
$74.77M
Operating income
$25.38M
Net income
$20.37M
Gross margin
41.2%
Net margin
11.2%
KMDA's net income is up by 27% year-on-year
Kamada's net margin has increased by 17% YoY
KMDA's revenue is up by 9% year-on-year
KMDA's gross margin is down by 7% year-on-year and by 2.6% since the previous quarter

Price vs fundamentals

How does KMDA's price correlate with its fundamentals

Growth

What is Kamada's growth rate over time

Valuation

What is Kamada stock price valuation
KMDA P/E details
P/E
20.74
P/B
1.61
P/S
2.31
EV/EBIT
17.2
EV/EBITDA
10.39
EV/Sales
2.19
Kamada's EPS has increased by 21% YoY
The price to earnings (P/E) is 3.5% lower than the last 4 quarters average of 21.5
The stock's price to book (P/B) is 24% more than its 5-year quarterly average of 1.3
KMDA's equity is down by 3.6% since the previous quarter but it is up by 2.9% year-on-year
KMDA's P/S is 10% above its 5-year quarterly average of 2.1 but 8% below its last 4 quarters average of 2.5
KMDA's revenue is up by 9% year-on-year

Efficiency

How efficient is Kamada business performance
KMDA's return on assets is up by 23% year-on-year
KMDA's return on equity is up by 22% year-on-year
Kamada's return on sales has increased by 17% YoY but it has decreased by 6% QoQ
The company's return on invested capital fell by 14% QoQ but it rose by 4.7% YoY

Dividends

What is KMDA's dividend history
DPS
$0.25
Dividend yield
3.44%
Payout ratio
71.4%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Kamada financials performed over time
Kamada's current ratio has decreased by 18% from the previous quarter
KMDA's quick ratio is down by 17% since the previous quarter
Kamada's debt is 96% less than its equity
Kamada's debt has increased by 4.9% YoY
KMDA's equity is down by 3.6% since the previous quarter but it is up by 2.9% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.